Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 5/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.72 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.72 |
| ▸ | HTR1A | P08908 | 3/20 | 0.72 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.72 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.72 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.72 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.72 |
| ▸ | DRD1 | P21728 | 3/20 | 0.72 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.72 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.72 |
| ▸ | DRD3 | P35462 | 3/20 | 0.72 |
| ▸ | THPO | P40225 | 3/20 | 0.72 |
| ▸ | MTOR | P42345 | 3/20 | 0.72 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.72 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.72 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.72 |
| ▸ | NPC1 | O15118 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7746782 | 0.95 | FPR2 (0.69) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL10168752 | 0.92 | FPR2 (0.82) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL561009 | 0.87 | FPR2 (0.82) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL14809956 | 0.87 | TP53 (0.72) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL561399 | 0.87 | LMNA (0.75) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL24439717 | 0.87 | FPR2 (0.78) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL10168007 | 0.86 | FPR2 (0.72) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL15805949 | 0.86 | TP53 (0.55) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL561173 | 0.86 | LMNA (0.73) | TP53MAPK1CYP1A2ABCB1HTR1A | |
| SCHEMBL16169647 | 0.85 | TP53 (0.57) | TP53MAPK1CYP1A2ABCB1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250034193-A1 | PHENOTHIAZINE DERIVATIVES AND USES THEREOF | CAMP4 THERAPEUTICS CORPORATION | 2025-01-30 | — | — | US | disclosed |
| US-12145963-B2 | Phenothiazine derivatives and uses thereof | CAMP4 THERAPEUTICS CORPORATION (US) | 2024-11-19 | — | — | US | disclosed |
| US-20240139178-A1 | METHOD FOR MANUFACTURING COMPOSITION FOR COMPOSITION FOR INCREASING COGNITIVE FUNCTION | AMYLOID SOLUTION INC. (KR) | 2024-05-02 | — | — | US | disclosed |
| US-20230257410-A1 | PHENOTHIAZINE DERIVATIVES AND USES THEREOF | CAMP4 THERAPEUTICS CORPORATION | 2023-08-17 | — | — | US | disclosed |
| US-20230257410-A1 | PHENOTHIAZINE DERIVATIVES AND USES THEREOF | CAMP4 THERAPEUTICS CORPORATION | 2023-08-17 | — | — | US | disclosed |
| US-20230257410-A1 | PHENOTHIAZINE DERIVATIVES AND USES THEREOF | CAMP4 THERAPEUTICS CORPORATION | 2023-08-17 | — | — | US | disclosed |
| US-11542290-B2 | Phenothiazine derivatives and uses thereof | CAMP4 THERAPEUTICS CORPORATION (US) | 2023-01-03 | — | — | US | disclosed |
| US-11542290-B2 | Phenothiazine derivatives and uses thereof | CAMP4 THERAPEUTICS CORPORATION (US) | 2023-01-03 | — | — | US | disclosed |
| EP-3888655-A1 | THERAPEUTIC COMPOSITION AND TREATMENT METHOD FOR AMYLOID NEUROLOGICAL DISEASES | Amyloid Solution Inc. (KR) | 2021-10-06 | — | — | EP | disclosed |
| US-20210061837-A1 | PHENOTHIAZINE DERIVATIVES AND USES THEREOF | CAMP4 THERAPEUTICS CORPORATION | 2021-03-04 | — | — | US | disclosed |
| US-20200330474-A1 | COMPOSITION AND METHOD FOR TREATMENT OF AMYLOID CRANIAL NEUROPATHY | AMYLOID SOLUTION INC. (KR) | 2020-10-22 | — | — | US | disclosed |
| WO-2020111824-A1 | THERAPEUTIC COMPOSITION AND TREATMENT METHOD FOR AMYLOID NEUROLOGICAL DISEASES | 아밀로이드솔루션 주식회사 | 2020-06-04 | — | — | WO | disclosed |
| WO-2019195789-A1 | PHENOTHIAZINE DERIVATIVES AND USES THEREOF | CAMP4 THERAPEUTICS CORPORATION (US) | 2019-10-10 | — | — | WO | disclosed |
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | CELLCEUTIX CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | CELLCEUTIX CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
| US-8383617-B2 | Treatment of protein aggregation diseases | PAD PHARMA LIMITED (GB) | 2013-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200330474-A1 | COMPOSITION AND METHOD FOR TREATMENT OF AMYLOID CRANIAL NEUROPATHY | MAPT, PSEN1, PYGB | TP53 3042/4885MAPK1 1395/4885CYP1A2 4438/4885 |
| US-20210061837-A1 | PHENOTHIAZINE DERIVATIVES AND USES THEREOF | RPLP2, RPS2, RPLP1 | TP53 1987/4885MAPK1 3288/4885CYP1A2 1724/4885 |
| US-20230257410-A1 | PHENOTHIAZINE DERIVATIVES AND USES THEREOF | RPLP2, RPS2, RPLP1 | TP53 1987/4885MAPK1 3288/4885CYP1A2 1724/4885 |
| US-20240139178-A1 | METHOD FOR MANUFACTURING COMPOSITION FOR COMPOSITION FOR INCREASING COGNITIVE FUNCTION | PSEN2, PSEN1, NEFM | TP53 1147/4885MAPK1 3697/4885CYP1A2 928/4885 |
| US-12145963-B2 | Phenothiazine derivatives and uses thereof | RPLP2, RPS2, RPLP1 | TP53 1987/4885MAPK1 3288/4885CYP1A2 1724/4885 |
| US-20250034193-A1 | PHENOTHIAZINE DERIVATIVES AND USES THEREOF | RPLP2, RPS2, RPLP1 | TP53 1987/4885MAPK1 3288/4885CYP1A2 1724/4885 |
| US-11542290-B2 | Phenothiazine derivatives and uses thereof | RPLP2, RPS2, RPLP1 | TP53 1987/4885MAPK1 3288/4885CYP1A2 1724/4885 |
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | ALG1, CD44, MUC1 | TP53 578/4885MAPK1 662/4885CYP1A2 4240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.